Chemcon Speciality Chemicals Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 4,676,469 (50%) | — | ₹15,900 Cr |
| NII (HNI) | — | 1,402,942 (15%) | — | ₹4,770 Cr |
| Retail | — | 3,273,530 (35%) | — | ₹11,130 Cr |
| Σ Total | — | 9,352,941 (100%) | — | ₹318,000 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 44 | ₹14,960 |
| Retail (Max) | 13 | 572 | ₹194,480 |
| S-HNI (Min) | 14 | 616 | ₹209,440 |
| B-HNI (Min) | 67 | 2,948 | ₹1,002,320 |
Financial Statements Amount In Crore
| Metric | 31-Mar-20 | 31-Mar-19 | 31-Mar-18 |
|---|---|---|---|
| Revenue | 266 | 305 | 158 |
| Profit After Tax | 49 | 43 | 26 |
| Total Assets | 226 | 173 | 97 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- 1 Capital expenditure towards expansion of Manufacturing Facility – 41.03
- 2 To meet working capital requirements – 90.00
- 3 General corporate purposes – 18.76
Company Overview
Incorporated in 1988, Chemcon Speciality Chemicals Ltd is a manufacturer of specialized chemical products i.e. HMDS and CMIC. Its product portfolio includes oilfield chemicals (Calcium Bromide, Sodium Bromide, and Zinc Bromide), Pharma intermediates, Silanes, and chemicals contract manufacturing work.
Chemcon Chemicals is a leading manufacturer of Pharmaceutical chemicals and generates maximum revenue from this particular segment. Hetero Labs Limited, Laurus Labs Ltd, Aurobindo Pharma Ltd, Lantech Pharmaceuticals Ltd, Macleods Pharma Ltd are the key customers of its Pharma chemical business. However, Shree Radha Overseas, Universal Drilling Fluids, Water Systems Speciality are some of the clients of its oilfield chemicals segment. In 2018, it was the 8th largest manufacturer of HMDS and 2nd largest manufacturer of CMIC chemical worldwide.
Company not only serves the domestic market but also export its products in overseas market such as USA, China, Japan, UAE, Serbia, Russia, Malaysia, and Azerbaijan. It has a manufacturing plant at Manjusar near Vadodara in Gujarat, 5 operational plants, 3 warehouses, and 2 leased warehouses.
Competitive strengths
• Largest manufacturer of pharmaceutical chemicals across the globe.
• Leading oilfield chemicals manufacturer in India.
• Diversified clientele base in the domestic and global markets.
• Strong and consistent financial performance.
• Dedicated manufacturing plants for each product.